At meeting held on 20 May 2022
The Board of Zydus Lifesciences at its meeting held on 20 May 2022 has approved buyback of up to 1,15,38,461 equity shares of face value of Re 1 each at a price of Rs 650 per share for an aggregate amount not exceeding Rs 750 crore.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
